Biotricity, Inc. BTCY
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 16.40M | 16.00M | 15.45M | 15.08M | 14.46M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.40M | 16.00M | 15.45M | 15.08M | 14.46M |
| Cost of Revenue | 3.04M | 3.05M | 2.92M | 3.04M | 3.14M |
| Gross Profit | 13.36M | 12.95M | 12.53M | 12.04M | 11.32M |
| SG&A Expenses | 9.05M | 8.49M | 9.89M | 10.09M | 10.03M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.83M | 14.31M | 15.31M | 15.55M | 15.51M |
| Operating Income | 1.57M | 1.69M | 141.10K | -468.80K | -1.05M |
| Income Before Tax | -2.69M | -2.40M | -4.02M | -4.53M | -5.40M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.69 | -2.40 | -4.02 | -4.53 | -5.40 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.69M | -2.40M | -4.02M | -4.53M | -5.40M |
| EBIT | 1.57M | 1.69M | 141.10K | -468.80K | -1.05M |
| EBITDA | 1.57M | 1.70M | 147.10K | -462.80K | -1.04M |
| EPS Basic | -0.13 | -0.12 | -0.18 | -0.19 | -0.23 |
| Normalized Basic EPS | -0.07 | -0.06 | -0.10 | -0.11 | -0.14 |
| EPS Diluted | -0.13 | -0.12 | -0.18 | -0.19 | -0.23 |
| Normalized Diluted EPS | -0.07 | -0.06 | -0.10 | -0.11 | -0.14 |
| Average Basic Shares Outstanding | 106.02M | 109.21M | 106.99M | 103.63M | 99.36M |
| Average Diluted Shares Outstanding | 106.02M | 109.21M | 106.99M | 103.63M | 99.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.90% | -1.00% | -0.60% | -0.53% | -0.44% |